Background/Objectives: The work investigates the effect of the estragole complex encapsulated in beta-cyclodextrin (ES/β-CD) in modulating bacterial resistance, specifically in Staphylococcus aureus strains expressing NorA and MepA efflux pumps. Efflux pumps are mechanisms that bacteria use to resist antibiotics by expelling them from the cell. Methodology: Several compounds and antibiotics, such as ciprofloxacin and norfloxacin, were used to evaluate the antimicrobial activity and the ability of the ES/β-CD complex to reverse resistance. Methods: The study included scanning electron microscopy assays, minimum inhibitory concentration (MIC) determination, and efflux pump inhibition tests. Results: The ES/β-CD complex did not show significant direct antibacterial activity. However, it modulated the action of norfloxacin, decreasing the MIC when combined with this antibiotic in the 1199B (NorA) strain. These results suggest a potential for synergy but not a direct inhibition of efflux pumps. Conclusion: ES/β-CD can potentiate the efficacy of some antibiotics but does not directly act as an efflux pump inhibitor; it is more of an antibiotic potentiator than a direct solution to bacterial resistance. The molecular docking simulation data suggest its high affinity for forming the ES/β-CD complex. The pharmacokinetic predictions based on MPO suggest that the compound has moderate lipophilicity, highly effective cellular permeability, and low incidence of organic toxicity, pointing to a promising pharmacological principle with controlled daily oral dosing. Conclusions: These results indicate this complex’s possible and relevant association as an adjuvant in antibiotic therapy to reduce multidrug-resistant bacteria; however, new in vivo assays are necessary to confirm this effect.

Clitoria fairchildiana is a common plant in Amazon rain forest. Popularly known as sombreiro, this plant has a great potential to use its phytochemical content for biological and medical applications. Stemonal, one of many phytochemical products extracted from “sobreiro”, presents cytotoxic and anti-inflamatory activities, which means that has great potential for pharmaceutical applications. In order to collaborate with stemonal research, this paper studied the molecular properties of this molecule. The molecular structure of stemonal was optimized using semi-empiric methods, such as PM3, using ArgusLab® software. Molecular parameters, such as frontier orbitals (HOMO and LUMO), MESP and formation enthalpy were obtained. Also, molecular docking experiments were conducted in order to evaluate the applicability over AChE, and the coupling of stemonal in this enzyme shows that the phytochemical binds into the catalytic site of the enzyme, which means that the molecule inhibits the hydrolysis of acethylcoline, the neurotransmitter evolved into skeletal muscules. Therefore, stemonal molecule has great potential to be applied into pharmaceutical formulations to achieve a better treatment for Alzheimer’s diesease.